| 摘要 |
This invention relates to the use of the hydrochloride salt of [IR &cir& _-[1 alpha (Z &cir& _),2 beta ,3 beta ,5 alpha ]]-(+)-7-[5-[[(1,1'-biphenyl)-4-yl]methoxy]-3-hydroxy-2-(1-piperidinyl)cyclopentyl]-4-heptenoic acid (i.e. Vapiprost) in the treatment of certain inflammatory diseases, including inflammatory bowel diseases. |
